# Lansoprazole

NDC: 0378-6982
Generic name: lansoprazole
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Routes: ORAL
Marketing started: 20181129

FDA application: ANDA202396

## Active ingredients

- LANSOPRAZOLE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-6982"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-6982
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20ff347c-ca18-497b-948d-1145035f2ffc